Sugaya, T.; Kanno, H.; Matsuda, M.; Handa, K.; Tateda, S.; Murakami, T.; Ozawa, H.; Itoi, E.
B-RAFV600E Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury. Cells 2019, 8, 1582.
https://doi.org/10.3390/cells8121582
AMA Style
Sugaya T, Kanno H, Matsuda M, Handa K, Tateda S, Murakami T, Ozawa H, Itoi E.
B-RAFV600E Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury. Cells. 2019; 8(12):1582.
https://doi.org/10.3390/cells8121582
Chicago/Turabian Style
Sugaya, Takehiro, Haruo Kanno, Michiharu Matsuda, Kyoichi Handa, Satoshi Tateda, Taishi Murakami, Hiroshi Ozawa, and Eiji Itoi.
2019. "B-RAFV600E Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury" Cells 8, no. 12: 1582.
https://doi.org/10.3390/cells8121582
APA Style
Sugaya, T., Kanno, H., Matsuda, M., Handa, K., Tateda, S., Murakami, T., Ozawa, H., & Itoi, E.
(2019). B-RAFV600E Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury. Cells, 8(12), 1582.
https://doi.org/10.3390/cells8121582